Cardiogenesis from human embryonic stem cells - Mechanisms and applications

Circulation Journal

Volumn 74, Issue 12, 2010, Pages 2517-2526

  Mignone, John L ^a   Kreutziger, Kareen L ^a   Paige, Sharon L ^a   Murry, Charles E ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b University of Washington   (United States)

Author keywords

Angiogenesis; Cardiomyocytes; Human embryonic stem cells; Myocardial infarction; Tissue engineering; Wnt signaling

Indexed keywords

ACTIVIN A; BETA CATENIN; BIOLOGICAL MARKER; BONE MORPHOGENETIC PROTEIN 4; CD31 ANTIGEN; DICKKOPF 1 PROTEIN; MYOSIN HEAVY CHAIN ALPHA; RNA; TRANSCRIPTION FACTOR NKX2.5; TRANSFORMING GROWTH FACTOR BETA; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN; WNT PROTEIN;

ALLOGENEIC STEM CELL TRANSPLANTATION; CELL DIFFERENTIATION; CELL FATE; CELL PROLIFERATION; CELL SURVIVAL; CORD BLOOD STEM CELL TRANSPLANTATION; DRESSLER SYNDROME; EMBRYO; EMBRYONIC STEM CELL; HEART ARRHYTHMIA; HEART DEVELOPMENT; HEART FAILURE; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART RATE VARIABILITY; HUMAN; HUMAN CELL CULTURE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; STEM CELL TRANSPLANTATION; THERAPY EFFECT; TISSUE ENGINEERING; TISSUE REGENERATION;

ANIMALS; CELL DIFFERENTIATION; CELL HYPOXIA; CELL LINE; CELL SURVIVAL; CORONARY CIRCULATION; EMBRYONIC STEM CELLS; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIUM; MYOCYTES, CARDIAC; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING;

EID: 78649707299     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-10-0958     Document Type: Review

References (44)

1. Jennings RB, Reimer KA. The cell biology of acute myocardial ischemia. Annu Rev Med 1991; 42: 225-246.
2. Mallory GK, White PD, Salcedo-Salga J. The speed of healing of myocardial infarction: A study of the pathologic anatomy in 72 cases. Am Heart J 1939; 18: 647-671.
3. Velagaleti RS, Pencina MJ, Murabito JM, Wang TJ, Parikh NI, D'Agostino RB, et al. Long-term trends in the incidence of heart failure after myocardial infarction. Circulation 2008; 118: 2057-2062.
4. Bergmann O, Bhardwaj RD, Bernard S, Zdunek S, Barnabé-Heider F, Walsh S, et al. Evidence for cardiomyocyte renewal in humans. Science 2009; 324: 98-102.
5. Reinecke H, Poppa V, Murry CE. Skeletal muscle stem cells do not transdifferentiate into cardiomyocytes after cardiac grafting. J Mol Cell Cardiol 2002; 34: 241-249.
6. Reinecke H, MacDonald GH, Hauschka SD, Murry CE. Electromechanical coupling between skeletal and cardiac muscle: Implications for infarct repair. J Cell Biol 2000; 149: 731-740.
7. Leobon B, Garcin I, Menasche P, Vilquin JT, Audinat E, Charpak S. Myoblasts transplanted into rat infarcted myocardium are functionally isolated from their host. Proc Natl Acad Sci USA 2003; 100: 7808-7811.
8. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B, et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001; 410: 701-705.
9. Tang XL, Rokosh DG, Guo Y, Bolli R. Cardiac progenitor cells and bone marrow-derived very small embryonic-like stem cells for cardiac repair after myocardial infarction. Circ J 2010; 74: 390-404.
10. Planat-Benard V, Menard C, Andre M, Puceat M, Perez A, Garcia- Verdugo JM, et al. Spontaneous cardiomyocyte differentiation from adipose tissue stroma cells. Circ Res 2004; 94: 223-229.
11. Beltrami AP, Barlucchi L, Torella D, Baker M, Limana F, Chimenti S, et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003; 114: 763-776.
12. Condorelli G, Borello U, De Angelis L, Latronico M, Sirabella D, Coletta M, et al. Cardiomyocytes induce endothelial cells to transdifferentiate into cardiac muscle: Implications for myocardium regeneration. Proc Natl Acad Sci USA 2001; 98: 10733-10738.
13. Schlechta B, Wiedemann D, Kittinger C, Jandrositz A, Bonaros NE, Huber JC, et al. Ex-vivo expanded umbilical cord blood stem cells retain capacity for myocardial regeneration. Circ J 2009; 74: 188-194.
14. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, et al. Embryonic stem cell lines derived from human blastocysts. Science 1998; 282: 1145-1147.
15. Murry CE, Reinecke H, Pabon LM. Regeneration gaps: Observations on stem cells and cardiac repair. J Am Coll Cardiol 2006; 47: 1777-1785.
16. Shiba Y, Hauch KD, Laflamme MA. Cardiac applications for human pluripotent stem cells. Curr Pharm Des 2009; 15: 2791-2806.
17. Freund C, Mummery CL. Prospects for pluripotent stem cellderived cardiomyocytes in cardiac cell therapy and as disease models. J Cell Biochem 2009; 107: 592-599.
18. Irion S, Nostro MC, Kattman SJ, Keller GM. Directed differentiation of pluripotent stem cells: From developmental biology to therapeutic applications. Cold Spring Harb Symp Quant Biol 2008; 73: 101-110.
19. Murry CE, Keller G. Differentiation of embryonic stem cells to clinically relevant populations: Lessons from embryonic development. Cell 2008; 132: 661-680.
20. Min JY, Yang Y, Converso KL, Liu L, Huang Q, Morgan JP, et al. Transplantation of embryonic stemcells improves cardiac function in postinfarcted rats. J Appl Physiol 2002; 92: 288-296.
21. Behfar A, Zingman LV, Hodgson DM, Rauzier JM, Kane GC, Terzic A, et al. Stem cell differentiation requires a paracrine pathway in the heart. FASEB J 2002; 16: 1558-1566.
22. Nussbaum J, Minami E, Laflamme MA, Virag JA, Ware CB, Masino A, et al. Transplantation of undifferentiated murine embryonic stem cells in the heart: Teratoma formation and immune response. FASEB J 2007; 21: 1345-1357.
23. Swijnenburg RJ, Tanaka M, Vogel H, Baker J, Kofidis T, Gunawan F, et al. Embryonic stem cell immunogenicity increases upon differentiation after transplantation into ischemic myocardium. Circulation 2005; 112: I166-I172.
24. Kehat I, Kenyagin-Karsenti D, Snir M, Segev H, Amit M, Gepstein A, et al. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest 2001; 108: 407-414.
25. Ladd AN, Yatskievych TA, Antin PB. Regulation of avian cardiac myogenesis by activin/TGFbeta and bone morphogenetic proteins. Dev Biol 1998; 204: 407-419.
26. Sugi Y, Sasse J, Barron M, Lough J. Developmental expression of fibroblast growth factor receptor-1 (cek-1; flg) during heart development. Dev Dyn 1995; 202: 115-125.
27. Laflamme MA, Chen KY, Naumova AV, Muskheli V, Fugate JA, Dupras SK, et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol 2007; 25: 1015-1024.
28. Yang L, Soonpaa MH, Adler ED, Roepke TK, Kattman SJ, Kennedy M, et al. Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population. Nature 2008; 453: 524-528.
29. Marvin MJ, Di Rocco G, Gardiner A, Bush SM, Lassar AB. Inhibition of Wnt activity induces heart formation from posterior mesoderm. Genes Dev 2001; 15: 316-327.
30. Schneider VA, Mercola M. Wnt antagonism initiates cardiogenesis in Xenopus laevis. Genes Dev 2001; 15: 304-315.
31. Nakamura T, Sano M, Songyang Z, Schneider MD. A Wnt- and beta-catenin-dependent pathway for mammalian cardiac myogenesis. Proc Natl Acad Sci USA 2003; 100: 5834-5839.
32. Ueno S, Weidinger G, Osugi T, Kohn AD, Golob JL, Pabon L, et al. Biphasic role for Wnt/beta-catenin signaling in cardiac specification in zebrafish and embryonic stem cells. Proc Natl Acad Sci USA 2007; 104: 9685-9690.
33. Paige SL, Osugi T, Afanasiev OK, Pabon L, Reinecke H, Murry CE. Endogenous Wnt/beta-catenin signaling is required for cardiac differentiation in human embryonic stem cells. PLoS One 2010; 5: 1-8.
34. Millauer B, Wizigmann-Voos S, Schnurch H, Martinez R, Moller NP, Risau W, et al. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 1993; 72: 835-846.
35. Drake CJ, Hungerford JE, Little CD. Morphogenesis of the first blood vessels. Ann NY Acad Sci 1998; 857: 155-179.
36. Kaufman DS, Lewis RL, Hanson ET, Auerbach R, Plendl J, Thomson JA. Functional endothelial cells derived from rhesus monkey embryonic stem cells. Blood 2004; 103: 1325-1332.
37. Vodyanik MA, Bork JA, Thomson JA, Slukvin II. Human embryonic stem cell-derived CD34+ cells: Efficient production in the coculture with OP9 stromal cells and analysis of lymphohematopoietic potential. Blood 2005; 105: 617-626.
38. Laflamme MA, Gold J, Xu C, Hassanipour M, Rosler E, Police S, et al. Formation of human myocardium in the rat heart from human embryonic stem cells. Am J Pathol 2005; 167: 663-671.
39. Kehat I, Khimovich L, Caspi O, Gepstein A, Shofti R, Arbel G, et al. Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat Biotechnol 2004; 22: 1282-1289.
40. Radisic M, Park H, Martens TP, Salazar-Lazaro JE, Geng W, Wang Y, et al. Pre-treatment of synthetic elastomeric scaffolds by cardiac fibroblasts improves engineered heart tissue. J Biomed Mater Res A 2008; 86: 713-724.
41. Bursac N, Loo Y, Leong K, Tung L. Novel anisotropic engineered cardiac tissues: Studies of electrical propagation. Biochem Biophys Res Commun 2007; 361: 847-853.
42. Gonen-Wadmany M, Gepstein L, Seliktar D. Controlling the cellular organization of tissue-engineered cardiac constructs. Ann NY Acad Sci 2004; 1015: 299-311.
43. Stevens KR, Pabon L, Muskheli V, Murry CE. Scaffold-free human cardiac tissue patch created from embryonic stem cells. Tissue Eng Part A 2009; 15: 1211-1222.
44. Stevens KR, Kreutziger KL, Dupras SK, Korte FS, Regnier M, Muskheli V, et al. Physiological function and transplantation of scaffold-free and vascularized human cardiac muscle tissue. Proc Natl Acad Sci USA 2009; 106: 16568-16573.